First Report of Severe Acute Graft-Versus-Host Disease After Allogeneic Stem Cell Transplant in a Patient With Myelodysplastic Syndrome Treated With Atezolizumab: Literature Review

Checkpoint inhibitors have become a widely used and available immunotherapy option for treating a variety of malignancies, including hematological malignancies. Patients receiving these therapies may go on to receive a curative allogeneic hematopoietic stem cell transplant (allo-HSCT). This presents...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsiao, Mindy, Tatishchev, Sergei, Khedro, Tarek, Yaghmour, Bassam, O’Connell, Casey, Yaghmour, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239570/
https://www.ncbi.nlm.nih.gov/pubmed/32494318
http://dx.doi.org/10.14740/wjon1263

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239570/
https://www.ncbi.nlm.nih.gov/pubmed/32494318
http://dx.doi.org/10.14740/wjon1263

Ejemplares similares